Table 1.
Univariate analysis of clinical characteristics, morphologies, and laboratory parameters.
| Variables | IST group (n = 12) | Non-IST group (n = 160) | p value |
|---|---|---|---|
| Clinical characteristics | |||
| Age, year | 54.92 ± 11.33 | 53.29 ± 9.08 | 0.557a |
| Gender | 0.249c | ||
| Male | 1 (8.33%) | 36 (22.50%) | |
| Female | 11 (91.67%) | 124 (77.50%) | |
| Aneurysm side | 0.535c | ||
| Left | 8 (66.67%) | 92 (57.50%) | |
| Right | 4 (33.33%) | 68 (42.50%) | |
| Smoking | 1 (8.33%) | 11 (6.88%) | 0.848c |
| Alcohol | 1 (8.33%) | 14 (8.75) | 0.961c |
| Hypertension | 6 (50.00%) | 43 (26.88%) | 0.087c |
| Diabetes mellitus | 0 (0.00%) | 8 (5.00%) | 0.428c |
| Hyperlipemia | 4 (33.33%) | 32 (20.00%) | 0.273c |
| Coronary heart disease | 1 (8.33%) | 4 (2.50%) | 0.246c |
| Stent type | 0.174c | ||
| Laser-cut | 8 (66.67%) | 132 (82.50%) | |
| Braided | 4 (33.33%) | 28 (17.50%) | |
| Operation time, min | 113.58 ± 33.49 | 70.00 ± 33.75 | < 0.001 b |
| Morphology | |||
| D max, mm | 9.59 ± 4.14 | 5.84 ± 3.05 | 0.004 b |
| H, mm | 5.47 ± 6.22 | 3.97 ± 2.36 | 0.001 b |
| W, mm | 7.52 ± 3.20 | 4.83 ± 2.13 | 0.013 b |
| H/W | 1.01 ± 0.23 | 0.81 ± 0.23 | 0.014 b |
| V, mm3 | 114.74 ± 462.81 | 40.38 ± 69.13 | 0.006 b |
| S, mm2 | 24.00 ± 40.69 | 19.60 ± 17.42 | 0.060b |
| N, mm | 5.53 ± 3.73 | 5.00 ± 2.22 | 0.060b |
| PD, mm | 3.87 ± 0.90 | 4.02 ± 0.66 | 0.218b |
| BNF | 1.01 ± 0.32 | 0.99 ± 0.19 | 0.560b |
| SR | 1.64 ± 1.89 | 1.02 ± 0.72 | 0.011 b |
| AR | 1.01 ± 0.39 | 0.79 ± 0.30 | 0.009 b |
| VNR | 5.25 ± 5.54 | 2.63 ± 2.29 | 0.018 b |
| Laboratory test | |||
| Red blood cell | 4.11 ± 0.44 | 4.24 ± 0.44 | 0.326a |
| Hemoglobin | 127.5 ± 11.75 | 126.93 ± 14.17 | 0.942b |
| White blood cell | 5.72 ± 1.48 | 5.25 ± 1.64 | 0.339b |
| Platelet | 212.17 ± 47.98 | 204.00 ± 61.75 | 0.831b |
| Cholesterol | 4.20 ± 0.97 | 4.23 ± 1.40 | 0.878b |
| Triglyceride | 1.28 ± 0.53 | 1.17 ± 0.77 | 0.692b |
| Blood Glucose | 5.13 ± 0.57 | 4.94 ± 0.81 | 0.705b |
| Prothrombin time | 12.94 ± 0.49 | 13.03 ± 0.55 | 0.590a |
| Prothrombin time activity | 105.42 ± 9.87 | 102.00 ± 14.00 | 0.364b |
| International normalized ratio | 0.98 ± 0.05 | 0.99 ± 0.08 | 0.361b |
| Fibrinogen | 2.97 ± 0.78 | 2.85 ± 0.73 | 0.489b |
| Activated partial thromboplastin time | 36.70 ± 9.68 | 36.85 ± 4.68 | 0.641b |
| Thrombin time | 16.88 ± 0.69 | 17.10 ± 1.25 | 0.514b |
| AA inhibition | 100.00 ± 2.10 | 100.00 ± 4.20 | 0.605b |
| ADP inhibition | 46.59 ± 12.74 | 65.10 ± 41.88 | 0.012 b |
| Reaction time | 4.81 ± 1.10 | 5.35 ± 1.40 | 0.023 b |
| kinetics time | 1.33 ± 0.45 | 1.30 ± 0.50 | 0.436b |
| Alpha angle | 75.95 ± 6.33 | 74.05 ± 8.15 | 0.148b |
| Maximum amplitude | 63.18 ± 4.04 | 62.10 ± 5.95 | 0.409b |
| Estimated percent lysis | 0.00 ± 0.00 | 1.35 ± 1.90 | 0.633b |
| Coagulation index | 1.73 ± 1.40 | 1.35 ± 1.90 | 0.251b |
| Lysis 30 min | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.496b |
p < 0.05 were in bold.
a performed independent t test, b non-parametric test, c chi-square test.
IST, In-stent thrombosis; D max, Maximum diameter; W, Width; H, Height; V, Volume; S, Space; N, Neck diameter; PD, Parent artery diameter; BNF, Bottleneck factor; SR, Size ratio; AR, Aspect ratio; VNR, Volume neck space ratio; AA, Arachidonic acid; and ADP, Adenosine diphosphate.